Correction: The anthelmintic drug niclosamide induces GSK-β-mediated β-catenin degradation to potentiate gemcitabine activity, reduce immune evasion ability and suppress pancreatic cancer progression

• Yangyang Guo,
• Hengyue Zhu,
• Yanyi Xiao,
• Hangcheng Guo,
• Miaomiao Lin,
• Ziwei Yuan,
• Xuejia Yang,
• Youze Huang,
• Qiyu Zhang,
• Yongheng Bai

Affiliations

Yangyang Guo

Key Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University

Hengyue Zhu

Key Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University

Yanyi Xiao

Key Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University

Hangcheng Guo

Key Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University

Miaomiao Lin

Key Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University

Ziwei Yuan

Key Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University

Xuejia Yang

Key Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University

Youze Huang

Department of Laboratory Medicine, Wenzhou Hospital of Traditional Chinese Medicine

Qiyu Zhang

Department for Hepatopancreatobiliary Surgery, The First Affiliated Hospital of Wenzhou Medical University

Yongheng Bai

Key Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University